Study identifies gene signature associated with resistance to cancer therapies

[News]

Agendia, an innovative molecular cancer diagnostics company and leader in personalized medicine, today announced the publication in the November 21st issue of the prestigious scientific journal "Cell" of a study that identifies a gene signature that is associated with resistance to a broad range of cancer therapies in multiple cancer types.

More... (http://www.news-medical.net/news/20121128/Study-identifies-gene-signature-associated-with-resistance-to-cancer-therapies.aspx)